MYC and esophageal cancer: Here we examined the utility of the small molecule CDK inhibitor flavopiridol and the insulin-like growth factor 1 receptor/insulin receptor (IGF-1R/IR) targeted agent BMS-754807 in the treatment of esophageal cancer with elevated expression of c-Myc.